The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients

Transplantation Proceedings

Volumn 31, Issue 5, 1999, Pages 1973-1975

  Miura, S ^a   Okazaki, H ^a   Sato, T ^a   Amada, N ^a   Ohashi, Y ^a   Hashizume, E ^a  

^a Sendai Shakaihoken Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN A; CYTOTOXIC ANTIBODY; LYMPHOCYTE ANTIBODY; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BLOOD TRANSFUSION; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TISSUE DONORS;

EID: 0032768015     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00233-X     Document Type: Article

References (10)

1. Patel R., Terasaki P.I. N Engl J Med. 280:1969;735.
2. Morris P.J., Ting A., Oliver D.O., et al. Lancet. 1:1977;1288.
3. Miura S., Okazaki H., Sato T., et al. Transplant Proc. 27:1995;1040.
4. Miura S., Okazaki H., Sato T., et al. Transplant Proc. 29:1997;350.
5. Iwaki Y., Terasaki P.I., Park M.S., et al. Lancet. 1:1978;1228.
6. Almond P.S., Matas A., Gillingham K., et al. Transplantation. 55:1993;752.
7. Mayer A.D., Dmitrewski J., Squifflet J.P., et al. Transplantation. 64:1997;436.
8. Morikawa K., Oseko F., Morikawa S. Transplantation. 54:1992;1025.
9. Suzuki N., Sakane T., Tsunematsu T. Clin Exp Immunol. 79:(2):1990;240.
10. Lyne J.C., Vivas C.A., Shapiro R., et al. Transplant Proc. 29:1997;312.